Since inflammatory cytokines and oxidative stress contribute substantially to the impairment of insulin action [31,35,36,37], the positive effects of propranolol towards improving gastrocnemius insulin action and hyperglycemia could be attributed to its suppressive effects on cytokine production and oxidative stress. This evidence concerns the gene INS and Hyperglycemia.